Literature DB >> 7806494

Characterization, partial purification, and peptide sequencing of p130,the main phosphoprotein associated with v-Crk oncoprotein.

R Sakai1, A Iwamatsu, N Hirano, S Ogawa, T Tanaka, J Nishida, Y Yazaki, H Hirai.   

Abstract

The transforming gene v-crk found in CT10 and ASV-1 avian sarcoma viruses induces marked phosphorylation of several proteins in cells expressing p47v-crk (v-Crk). In this work, the main tyrosine-phosphorylated proteins in ASV-1-infected chicken cells and v-crk-transfected rat cells were characterized biochemically. Both these proteins have a molecular mass of about 130 kDa and are tightly associated with v-Crk in vivo. Two-dimensional gel electrophoresis revealed that they are both essentially single proteins (p130) with modifications that result in a broad spot in an acidic region. The broad band of semi-purified p130 became sharp at an elevated position in the gel upon treatment with orthovanadate in vivo or with c-Src kinase produced using a baculovirus vector in vitro, whereas it shifted at a lower position upon treatment with alkaline phosphatase in vitro. These results suggest multiple phosphorylation states of p130, which result in a broad band of p130. Two procedures of immunoaffinity purification were used to purify p130 from 3Y1 cells transfected with v-crk. Approximately 30 pmol of purified p130 was obtained in an immobilized form on a filter starting from 3 x 10(10) cells. Peptide mapping of p130 digested in situ by peptidase revealed that the purity and quantity of the final material were enough for peptide sequencing. Several stretches of partial amino acid sequences were determined, and they indicated that p130 is a novel protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806494

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics.

Authors:  G M O'Neill; E A Golemis
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Individual Cas phosphorylation sites are dispensable for processive phosphorylation by Src and anchorage-independent cell growth.

Authors:  Parag Patwardhan; Yongquan Shen; Gary S Goldberg; W Todd Miller
Journal:  J Biol Chem       Date:  2006-05-17       Impact factor: 5.157

3.  Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST.

Authors:  A J Garton; A J Flint; N K Tonks
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  Requirements for localization of p130cas to focal adhesions.

Authors:  T Nakamoto; R Sakai; H Honda; S Ogawa; H Ueno; T Suzuki; S Aizawa; Y Yazaki; H Hirai
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.

Authors:  Yingshe Zhao; Joerg Kumbrink; Bor-Tyh Lin; Amy H Bouton; Shi Yang; Paul A Toselli; Kathrin H Kirsch
Journal:  Carcinogenesis       Date:  2013-07-03       Impact factor: 4.944

6.  CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases.

Authors:  T Nakamoto; T Yamagata; R Sakai; S Ogawa; H Honda; H Ueno; N Hirano; Y Yazaki; H Hirai
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Regulation of c-SRC activity and function by the adapter protein CAS.

Authors:  M R Burnham; P J Bruce-Staskal; M T Harte; C L Weidow; A Ma; S A Weed; A H Bouton
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 8.  Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members.

Authors:  Alexander Deneka; Vladislav Korobeynikov; Erica A Golemis
Journal:  Gene       Date:  2015-06-26       Impact factor: 3.688

9.  Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation.

Authors:  J Zheng; K Machida; S Antoku; K Y Ng; K P Claffey; B J Mayer
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

10.  Puromycin aminonucleoside modulates p130Cas of podocytes.

Authors:  Tae-Sun Ha; Ji-Young Choi; Hye-Young Park
Journal:  Korean J Pediatr       Date:  2012-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.